Monogram Biosciences Inc.

Monogram Biosciences Inc. of South San Francisco, Calif., has licensed a large share of its microfluidics patent portfolio to Caliper Life Sciences Inc. of Hopkinton, Mass. The licensed intellectual property originates from Aclara BioSciences Inc. of Mountain View, Calif., which merged with Monogram in 2004. Monogram will retain the right to exploit the property for use with its eTag protein drug target and signaling pathway assays.





LATEST NEWS

• Exail Signs LLNL Contract, Partners with Eelume
  Apr 26, 2024
• Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
  Apr 26, 2024
• Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
  Apr 25, 2024
• DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
  Apr 25, 2024
• Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
  Apr 24, 2024
• One-Step Hologram Generation Speeds 3D Display Creation
  Apr 24, 2024
• Innovation Award Winners for Laser Technology Honored in Aachen
  Apr 23, 2024
• Intech 2024: AI Arrives on the Shop Floor
  Apr 22, 2024